ArticleCancers2021

Adapter Chimeric Antigen Receptor (AdCAR)-Engineered NK-92 Cells for the Multiplex Targeting of Bone Metastases.

Stefan Grote et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.